Unlocking CDMO growth via commercial excellence

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kaan-Fabian Kekec, Partner in Healthcare and Life Sciences at Simon-Kucher.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kaan, covering:

• Being on the sunny side of consulting, and helping clients unlock growth.
• What makes a key strategic partnership both from a CDMO, and a sponsor perspective.
• The taboo subject of pricing and how it can be used to help unlock commercial positioning, and excellence.
• Common mistakes in BD teams, and the importance of value positioning.
• The hottest segments in the market right now, and some of the competitive drivers in today's market.

Kaan leads the firm’s Healthcare B2B and Pharma Services business globally, encompassing CDMOs, CROs, bioprocessing solutions, drug delivery, packaging, and more.

He specializes in delivering end-to-end commercial strategies for CDMOs, advising on growth initiatives and supporting clients throughout the entire lead-to-deal process—from marketing and sales to proposal management and deal optimization.

Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by Lead Candidate. 

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!